Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease

[1]  B. Nordestgaard,et al.  Socioeconomic Status and Prognosis of COPD in Denmark , 2014, COPD.

[2]  C. Camargo,et al.  Epidemiology of emergency department visits for opioid overdose: a population-based study. , 2014, Mayo Clinic proceedings.

[3]  Jonathan M Mansbach,et al.  Temporal Trends in Emergency Department Visits for Bronchiolitis in the United States, 2006 to 2010 , 2014, The Pediatric infectious disease journal.

[4]  M. Weinberger,et al.  Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks. , 2013, Chest.

[5]  Y. Kuo,et al.  Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease. , 2013, The American journal of medicine.

[6]  D. Mannino,et al.  COPD Surveillance—United States, 1999-2011 , 2013, Chest.

[7]  W. Baine,et al.  The Agency for Healthcare Research and Quality , 2006, Italian Journal of Public Health.

[8]  A. Gillissen.  [Acute exacerbation of chronic obstructive pulmonary disease]. , 2012, MMW Fortschritte der Medizin.

[9]  R. Aungst,et al.  Healthy People 2020 , 2013, American Journal of Kidney Diseases.

[10]  J. Wedzicha,et al.  Controversies in treatment of chronic obstructive pulmonary disease , 2011, The Lancet.

[11]  J. Hokanson,et al.  The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. , 2011, Chest.

[12]  A. Elixhauser,et al.  Readmissions for Chronic Obstructive Pulmonary Disease, 2008 , 2011 .

[13]  J. Guo,et al.  Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010. , 2011, American health & drug benefits.

[14]  Leah N. Bryan,et al.  Influenza vaccination coverage - United States, 2000-2010. , 2011, MMWR supplements.

[15]  Gulshan Sharma,et al.  Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. , 2010, Archives of internal medicine.

[16]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[17]  Edwin K Silverman,et al.  Chronic obstructive pulmonary disease phenotypes: the future of COPD. , 2010, American journal of respiratory and critical care medicine.

[18]  Navkiran K. Shokar,et al.  Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Clinic , 2009, COPD.

[19]  C. Rand,et al.  Addressing asthma health disparities: a multilevel challenge. , 2009, The Journal of allergy and clinical immunology.

[20]  E. Walters,et al.  Self-management education for patients with chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.

[21]  L. Mobley,et al.  Do HMOs Reduce Preventable Hospitalizations for Medicare Beneficiaries? , 2007, Medical care research and review : MCRR.

[22]  Hoangmai H Pham,et al.  Potentially Avoidable Hospitalizations for COPD and Pneumonia: The Role of Physician and Practice Characteristics , 2007, Medical care.

[23]  C. Camargo,et al.  Factors Associated with Frequency of Emergency Department Visits for Chronic Obstructive Pulmonary Disease Exacerbation , 2007, Journal of General Internal Medicine.

[24]  Chu-Lin Tsai.  Appropriate statistical treatment of frequent emergency department visits in health services research. , 2007, Annals of emergency medicine.

[25]  G. Donaldson,et al.  COPD exacerbations · 1: Epidemiology , 2006, Thorax.

[26]  C. Camargo,et al.  Prospective multicenter study of relapse following emergency department treatment of COPD exacerbation. , 2004, Chest.

[27]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[28]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[29]  S. Kim.  Prospective Multicenter Study of Relapse Following Emergency Department Treatment of COPD Exacerbation , 2002 .

[30]  N. Anthonisen,et al.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.

[31]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[32]  S. Sullivan,et al.  The costs of treating COPD in the United States. , 2001, Chest.

[33]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[34]  J. Buring,et al.  Ways of measuring rates of recurrent events , 1996, BMJ.

[35]  G. Pugliese,et al.  Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.

[36]  J. Maurer.  The Chronic Bronchitic Phenotype of COPD: An Analysis of the COPDGene Study , 2012 .

[37]  R. Sakalauskas,et al.  [Diagnosis and management of chronic obstructive pulmonary disease]. , 2005, Medicina.

[38]  T. Stockdale,et al.  Population estimates. , 2004, Health statistics quarterly.

[39]  Christine Jenkins,et al.  GOLD SCIENTIFIC COMMITTEE. GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. NHLBI/WHO GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) WORKSHOP SUMMARY , 2001 .

[40]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.